InspireMD, Inc.
NSPR
$1.94
-$0.04-2.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.04% | 7.60% | 8.49% | 12.96% | 24.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.04% | 7.60% | 8.49% | 12.96% | 24.70% |
| Cost of Revenue | 10.65% | 11.54% | 16.21% | 25.13% | 32.97% |
| Gross Profit | 25.68% | -4.98% | -12.75% | -16.66% | 2.80% |
| SG&A Expenses | 72.29% | 52.81% | 39.96% | 42.80% | 41.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.72% | 46.56% | 45.42% | 48.14% | 42.83% |
| Operating Income | -56.62% | -56.00% | -55.32% | -58.46% | -47.72% |
| Income Before Tax | -63.79% | -62.31% | -59.46% | -60.93% | -45.75% |
| Income Tax Expenses | -9.23% | -9.23% | -9.23% | -9.23% | 132.14% |
| Earnings from Continuing Operations | -63.62% | -62.13% | -59.26% | -60.70% | -45.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.62% | -62.13% | -59.26% | -60.70% | -45.88% |
| EBIT | -56.62% | -56.00% | -55.32% | -58.46% | -47.72% |
| EBITDA | -56.64% | -56.17% | -55.62% | -58.88% | -48.05% |
| EPS Basic | -12.29% | -12.57% | -4.61% | 28.10% | 50.76% |
| Normalized Basic EPS | -12.43% | -12.72% | -4.73% | 28.09% | 50.77% |
| EPS Diluted | -12.29% | -12.57% | -4.61% | 28.37% | 50.89% |
| Normalized Diluted EPS | -12.43% | -12.72% | -4.73% | 28.09% | 50.77% |
| Average Basic Shares Outstanding | 46.83% | 43.94% | 48.97% | 72.95% | 113.69% |
| Average Diluted Shares Outstanding | 46.83% | 43.94% | 48.97% | 72.95% | 113.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |